Page 1 of 40
NURS 316 PHARMACOLOGY EXAM 1 2026/2027
COMPLETE CURRENT TESTING QUESTIONS AND
CORRECT ANSWERS WITH DETAILED RATIONALES.
PHARMACOLOGY
Prepare for NURS 316 Pharmacology Exam 1 with this focused study resource
designed to reinforce essential pharmacology concepts and medication-related
nursing knowledge. Use it to review drug classifications, pharmacologic principles,
therapeutic effects, adverse reactions, and safe medication practices. This resource
can help strengthen your understanding, identify areas that need additional study, and
improve exam readiness. It provides a structured supplement to your coursework for a
more confident approach to Exam 1.
MULTIPLE CHOICE.
Module 1: Foundations of Pharmacology (Questions 1–20)
1. A nurse is teaching a patient about medication absorption. Which
statement best describes the process of absorption?
A. The movement of a drug from the bloodstream to the site of action
B. The movement of a drug from its site of administration into the bloodstream
C. The chemical alteration of a drug to a more water-soluble form
D. The elimination of a drug from the body through the kidneys
Answer: B
Rationale: Absorption is the process by which a drug moves from its site
of administration into the bloodstream. Distribution (A) is the transport of
drugs from the bloodstream to tissues. Metabolism (C) is chemical
alteration. Excretion (D) is elimination from the body.
2. A patient asks the nurse why his oral medication is not working as
quickly as the IV medication he received in the hospital. Which response
by the nurse is most accurate?
A. "IV medications are stronger than oral medications."
B. "Oral medications must be absorbed through the gastrointestinal tract
before entering the bloodstream, which takes longer."
, Page 2 of 40
C. "Your body has developed a tolerance to the oral medication."
D. "The oral medication is probably expired."
Answer: B
Rationale: Oral medications must undergo absorption through the GI tract
before reaching the bloodstream, which delays their onset compared to
IV medications. IV administration bypasses absorption entirely, providing
100% bioavailability.
3. Which pharmacokinetic process involves the movement of a drug from
the bloodstream into tissues and organs?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Answer: B
Rationale: Distribution is the movement of a drug from the bloodstream
into tissues and organs. Absorption is movement from the site of
administration into the blood. Metabolism is the chemical alteration of
the drug. Excretion is the removal of the drug from the body.
4. Which statement best describes the concept of a drug's half-life (t½)?
A. The time required for the drug to be completely eliminated from the body
B. The time required for the plasma concentration of the drug to decrease by
50%
C. The time required for the drug to reach its maximum effect
D. The time required for the drug to be absorbed
Answer: B
Rationale: The half-life is the time required for the plasma concentration
of a drug to decrease by 50%. It takes approximately 4–5 half-lives to
reach steady state or to eliminate most of the drug from the body.
5. A patient is taking a drug that is highly protein-bound. Which situation
could increase the free (active) fraction of the drug and potentially cause
toxicity?
A. Increased albumin levels
, Page 3 of 40
B. Decreased albumin levels
C. Increased renal excretion
D. Increased hepatic metabolism
Answer: B
Rationale: Decreased albumin levels (e.g., in malnutrition, liver disease,
or nephrotic syndrome) reduce the number of binding sites, increasing
the free (active) fraction of highly protein-bound drugs, which can lead to
toxicity.
6. Which of the following best describes a drug's therapeutic index?
A. The ratio of the toxic dose to the therapeutic dose
B. The ratio of the effective dose to the lethal dose
C. The time required for the drug to reach peak effect
D. The percentage of the drug that is absorbed
Answer: A
Rationale: The therapeutic index is the ratio of the toxic dose to the
therapeutic dose. A narrow therapeutic index means there is a small
margin between therapeutic and toxic doses, requiring careful
monitoring.
7. A patient is prescribed a drug that is a potent enzyme inducer. Which
effect would this have on another drug metabolized by the same enzyme?
A. Increased plasma levels of the second drug
B. Decreased plasma levels of the second drug
C. No effect on the second drug
D. Increased toxicity of the second drug
Answer: B
Rationale: Enzyme inducers increase the activity of metabolic enzymes,
leading to faster metabolism and decreased plasma levels of drugs
metabolized by the same enzyme. This can reduce the therapeutic effect
of the second drug.
8. Which receptor type is directly coupled to ion channels and mediates
rapid responses?
A. G protein-coupled receptors
, Page 4 of 40
B. Ligand-gated ion channels
C. Nuclear receptors
D. Tyrosine kinase receptors
Answer: B
Rationale: Ligand-gated ion channels are directly coupled to ion channels
and mediate rapid responses, such as those seen with neurotransmitters.
G protein-coupled receptors and nuclear receptors mediate slower
responses.
9. A patient is taking a drug that acts as a competitive antagonist. What
effect does this have on the agonist dose-response curve?
A. It shifts the curve to the right.
B. It shifts the curve to the left.
C. It decreases the maximal efficacy.
D. It has no effect on the curve.
Answer: A
Rationale: A competitive antagonist shifts the agonist dose-response
curve to the right, meaning higher doses of the agonist are needed to
achieve the same effect. It does not decrease maximal efficacy if enough
agonist is available.
10. Which of the following is an example of a drug that acts via a non-
receptor mechanism?
A. Morphine
B. Insulin
C. Omeprazole
D. Propranolol
Answer: C
Rationale: Omeprazole acts by inhibiting the proton pump (H+/K+ ATPase)
directly, which is a non-receptor mechanism. Morphine, insulin, and
propranolol act via receptor-mediated mechanisms.
11. A patient develops tolerance to a drug after long-term use. Which
mechanism best explains this phenomenon?
A. Increased receptor sensitivity
NURS 316 PHARMACOLOGY EXAM 1 2026/2027
COMPLETE CURRENT TESTING QUESTIONS AND
CORRECT ANSWERS WITH DETAILED RATIONALES.
PHARMACOLOGY
Prepare for NURS 316 Pharmacology Exam 1 with this focused study resource
designed to reinforce essential pharmacology concepts and medication-related
nursing knowledge. Use it to review drug classifications, pharmacologic principles,
therapeutic effects, adverse reactions, and safe medication practices. This resource
can help strengthen your understanding, identify areas that need additional study, and
improve exam readiness. It provides a structured supplement to your coursework for a
more confident approach to Exam 1.
MULTIPLE CHOICE.
Module 1: Foundations of Pharmacology (Questions 1–20)
1. A nurse is teaching a patient about medication absorption. Which
statement best describes the process of absorption?
A. The movement of a drug from the bloodstream to the site of action
B. The movement of a drug from its site of administration into the bloodstream
C. The chemical alteration of a drug to a more water-soluble form
D. The elimination of a drug from the body through the kidneys
Answer: B
Rationale: Absorption is the process by which a drug moves from its site
of administration into the bloodstream. Distribution (A) is the transport of
drugs from the bloodstream to tissues. Metabolism (C) is chemical
alteration. Excretion (D) is elimination from the body.
2. A patient asks the nurse why his oral medication is not working as
quickly as the IV medication he received in the hospital. Which response
by the nurse is most accurate?
A. "IV medications are stronger than oral medications."
B. "Oral medications must be absorbed through the gastrointestinal tract
before entering the bloodstream, which takes longer."
, Page 2 of 40
C. "Your body has developed a tolerance to the oral medication."
D. "The oral medication is probably expired."
Answer: B
Rationale: Oral medications must undergo absorption through the GI tract
before reaching the bloodstream, which delays their onset compared to
IV medications. IV administration bypasses absorption entirely, providing
100% bioavailability.
3. Which pharmacokinetic process involves the movement of a drug from
the bloodstream into tissues and organs?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Answer: B
Rationale: Distribution is the movement of a drug from the bloodstream
into tissues and organs. Absorption is movement from the site of
administration into the blood. Metabolism is the chemical alteration of
the drug. Excretion is the removal of the drug from the body.
4. Which statement best describes the concept of a drug's half-life (t½)?
A. The time required for the drug to be completely eliminated from the body
B. The time required for the plasma concentration of the drug to decrease by
50%
C. The time required for the drug to reach its maximum effect
D. The time required for the drug to be absorbed
Answer: B
Rationale: The half-life is the time required for the plasma concentration
of a drug to decrease by 50%. It takes approximately 4–5 half-lives to
reach steady state or to eliminate most of the drug from the body.
5. A patient is taking a drug that is highly protein-bound. Which situation
could increase the free (active) fraction of the drug and potentially cause
toxicity?
A. Increased albumin levels
, Page 3 of 40
B. Decreased albumin levels
C. Increased renal excretion
D. Increased hepatic metabolism
Answer: B
Rationale: Decreased albumin levels (e.g., in malnutrition, liver disease,
or nephrotic syndrome) reduce the number of binding sites, increasing
the free (active) fraction of highly protein-bound drugs, which can lead to
toxicity.
6. Which of the following best describes a drug's therapeutic index?
A. The ratio of the toxic dose to the therapeutic dose
B. The ratio of the effective dose to the lethal dose
C. The time required for the drug to reach peak effect
D. The percentage of the drug that is absorbed
Answer: A
Rationale: The therapeutic index is the ratio of the toxic dose to the
therapeutic dose. A narrow therapeutic index means there is a small
margin between therapeutic and toxic doses, requiring careful
monitoring.
7. A patient is prescribed a drug that is a potent enzyme inducer. Which
effect would this have on another drug metabolized by the same enzyme?
A. Increased plasma levels of the second drug
B. Decreased plasma levels of the second drug
C. No effect on the second drug
D. Increased toxicity of the second drug
Answer: B
Rationale: Enzyme inducers increase the activity of metabolic enzymes,
leading to faster metabolism and decreased plasma levels of drugs
metabolized by the same enzyme. This can reduce the therapeutic effect
of the second drug.
8. Which receptor type is directly coupled to ion channels and mediates
rapid responses?
A. G protein-coupled receptors
, Page 4 of 40
B. Ligand-gated ion channels
C. Nuclear receptors
D. Tyrosine kinase receptors
Answer: B
Rationale: Ligand-gated ion channels are directly coupled to ion channels
and mediate rapid responses, such as those seen with neurotransmitters.
G protein-coupled receptors and nuclear receptors mediate slower
responses.
9. A patient is taking a drug that acts as a competitive antagonist. What
effect does this have on the agonist dose-response curve?
A. It shifts the curve to the right.
B. It shifts the curve to the left.
C. It decreases the maximal efficacy.
D. It has no effect on the curve.
Answer: A
Rationale: A competitive antagonist shifts the agonist dose-response
curve to the right, meaning higher doses of the agonist are needed to
achieve the same effect. It does not decrease maximal efficacy if enough
agonist is available.
10. Which of the following is an example of a drug that acts via a non-
receptor mechanism?
A. Morphine
B. Insulin
C. Omeprazole
D. Propranolol
Answer: C
Rationale: Omeprazole acts by inhibiting the proton pump (H+/K+ ATPase)
directly, which is a non-receptor mechanism. Morphine, insulin, and
propranolol act via receptor-mediated mechanisms.
11. A patient develops tolerance to a drug after long-term use. Which
mechanism best explains this phenomenon?
A. Increased receptor sensitivity
